Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (15,774,462)	$ (10,344,633)
Adjustments to reconcile net loss to net cash used in operating activities
Compensation cost for stock options granted	3,647,999	2,387,829
Disposal of assets	0	4,149
Depreciation and amortization	21,265	37,265
Changes in operating assets and liabilities:
Prepaid expenses	(69,295)	(621,907)
Research and development tax rebate receivable	(299,732)	300,451
Other assets	643,412	(152,781)
Accounts payable	(920,625)	389,441
Accrued expenses	(17,672)	7,285
Payroll liabilities	(50,995)	(146,573)
Other current liabilities	13,503	1,779
Net cash used in operating activities	(12,806,602)	(8,137,695)
CASH FLOWS FROM INVESTING ACTIVITY
Purchase of furniture and equipment	(9,396)	(9,367)
Net cash used in investing activities	(9,396)	(9,367)
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from issuance of common stock, net of issuance costs	0	4,686,298
Proceeds from issuance of common stock and warrants, net of issuance costs	69,668,408	0
Payment of taxes related to net-exercise of employee stock options	(574,867)	(14,422)
Proceeds from exercise of employee stock options	391,332	0
Proceeds from exercise of warrants	43,818,409	0
Net cash provided by financing activities	113,303,282	4,671,876
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	100,487,284	(3,475,186)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING BALANCE	39,663,671	12,691,136
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	140,150,955	9,215,950
SUPPLEMENTAL DISCLOSURES
Cash and cash equivalents	140,040,955	9,105,950
Restricted cash	110,000	110,000
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	140,150,955	9,215,950
NONCASH INVESTING AND FINANCING ACTIVITIES
Common stock issued upon cashless exercise of stock options	1,331,241	541,100
Reclassification of the warrant liability to equity upon adoption of accounting standard	13,003,075	0
Conversion of Series B Convertible Preferred Stock into Common Stock [Member]
NONCASH INVESTING AND FINANCING ACTIVITIES
Conversion of convertible preferred stock to common stock	$ 37,000	$ 48,000